No significant morbidity from recurrence cancer and no development of secondary type of cancers in pre-existing malignancies. We must be careful about risk of rejection.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435231 | PMC |
http://dx.doi.org/10.1002/ccr3.4810 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!